Precision Genetic Engineering for the Premier Industrial Filamentous Fungus. Aspergillus niger is a cornerstone of industrial biotechnology, renowned for its capacity to secrete organic acids, enzymes, and secondary metabolites. CD Biosynsis provides professional Aspergillus niger CRISPR-Cas9 Genome Editing Services, offering a sophisticated toolkit designed specifically for this filamentous fungus. Our platform integrates advanced delivery methods, including Ribonucleoprotein (RNP) complexes and multiplexing vectors, to enable marker-free, "scarless" genomic alterations for superior cell factory optimization.
Get a Technical QuoteOur Aspergillus niger platform supports diverse applications ranging from basic fungal biology to large-scale industrial biomanufacturing. We focus on providing high-efficiency modifications in complex multinucleated systems using the latest CRISPR modalities.
| Service Tier | Technical Focus | Primary Application | Industrial/Research Value |
|---|---|---|---|
| Marker-Free Gene Knockout | RNP-mediated disruption | Enzyme & Organic acid optimization | Eliminates genomic scars & selection drag |
| Large Cluster Deletion | Deletion of 10–50+ kb regions | Safety strain engineering (Toxin removal) | Simplifies genome for cleaner production |
| Metabolic Pathway Integration | Precise KI at "Safe Harbor" loci | Heterologous protein & Biofuel synthesis | Ensures stable, high-level cargo expression |
| Epigenetic Transcription Tuning | CRISPR-dCas9 (HAT/HDAC fusions) | Secondary metabolite activation | Unlocks "silent" biosynthetic gene clusters |
| High-Throughput Libraries | Microtiter plate-scale RNP editing | Enzyme evolution & Screening | Accelerates superior strain development |
1. Chassis Analysis
2. RNP & Vector Prep
3. Transformation
4. Metabolic Validation
Comprehensive analysis of the target Aspergillus niger strain to design optimal gRNAs and donor templates for complex genomic regions.
Technical project feasibility study and Mutual NDA signing.
In vitro preparation of high-purity Cas9 protein and specialized guide RNAs, or construction of fungal-specific expression vectors.
Optimization of RNP stoichiometry for maximum editing efficiency.
Protoplast-mediated transformation or biolistic delivery optimized for the thick cell walls of filamentous fungi.
Single-spore purification to ensure homokaryotic edited strains.
Rapid screening using microtiter plates followed by phenotypic assessment through fermentation profiling and HPLC analysis.
Final delivery of engineered fungal strains and detailed characterization dossiers.
We benchmark our precision engineering against landmark Aspergillus research to deliver world-class results.
Secondary metabolites are often regulated at the chromatin level. Technical benchmarks have demonstrated using CRISPR/dCas9 fused with histone modifiers (HATs/HDACs) to target specific clusters in A. niger. By modulating acetylation states (e.g., H3K9ac), researchers revealed how epigenetic markers dictate metabolic output, providing new strategies for natural product control.
(Reference: Li et al., Microbiol. Res., 2021)
To enhance high-value chemicals like succinic acid, "scarless" editing is essential. Utilizing in vitro assembled RNP complexes, researchers successfully knocked out competitive pathways in A. niger without leaving selection markers. This high-efficiency metabolic engineering approach significantly boosted yields from renewable biomass.
(Reference: Yang et al., Biotechnol. Biofuels, 2020)
Removal of harmful toxins is vital for industrial fungi safety. Using CRISPR-Cas9, technical teams achieved the precise deletion of massive gene clusters (up to 48 kb), such as Fumonisin B1 biosynthetic clusters. This "designer chromosome" approach eliminates undesirable metabolites, creating safer host strains.
(Reference: PLoS ONE, 2015/2024)
Rapidly evolving strains for substrate conversion requires high-throughput tools. Benchmarks have established microtiter plate-scale transformation methods utilizing RNP complexes. This platform enabled the rapid editing of multiple targets to create strains optimized for D-galactonic acid production, facilitating large-scale mutant library construction.
(Reference: Kuivanen et al., Fungal Biol. Biotechnol., 2022)
Ready to unlock the full industrial potential of your Aspergillus niger strains?
Contact Us1. Why choose RNP delivery over plasmid-based CRISPR for A. niger?
RNP delivery provides transient editing activity. Since the machinery degrades quickly, there is no risk of long-term off-target activity or permanent integration of foreign DNA, resulting in a cleaner, "non-GMO-like" final strain.
2. How do you handle the multinucleated nature of hyphal cells?
We utilize specialized protoplast isolation and meticulous single-spore purification techniques to ensure that the resulting edited strain is homokaryotic (all nuclei carry the intended modification).
3. Can you perform multiplexed editing in a single transformation?
Yes. Our platform supports the simultaneous targeting of multiple genes, allowing for the comprehensive rewiring of entire metabolic pathways in a significantly shorter timeframe.
4. Is this service applicable to proprietary industrial strains?
Absolutely. We can optimize our transformation and editing protocols for various Aspergillus niger lineages, including wild-type isolates and highly engineered industrial production strains.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.